Pharma 4.0 e a realidade no Brasil
Arquivos
Data
2022-12-09
Autores
Rinaldi, Bruna Gomes 
Orientadores
Lopes, Patrícia Santos
Tipo
Trabalho de conclusão de curso
Título da Revista
ISSN da Revista
Título de Volume
Resumo
As grandes revoluções industriais foram eventos necessários e disruptivos que causaram grande impacto na sociedade, trazendo desenvolvimento econômico e social. A indústria 4.0 é um conceito situado dentro da quarta revolução industrial que trouxe tecnologias como internet das coisas, big data, inteligência artificial e computação em nuvem, que juntas são capazes de conectar máquinas e sistemas, criando redes inteligentes e autônomas. Com a implementação das novas tecnologias, é possível aumentar de forma significativa a agilidade, eficiência, flexibilidade e qualidade da produção industrial e proporcionar novos modelos de negócios. Na indústria farmacêutica, esta abordagem é denominada de Pharma 4.0. Atualmente a indústria farmacêutica brasileira está estruturada nos moldes da terceira revolução industrial, mas ainda não atingiu toda sua magnitude, pois boa parte dos processos são manuais ou parcialmente automatizados. Com exigências cada vez maiores para a fabricação de medicamentos, as indústrias precisam se tornar cada vez mais competitivas em nível global, sendo necessário maiores investimentos, para que seus processos sejam cada vez mais otimizados e enxutos e os produtos mais seguros e eficazes. Para alcançar o nível de maturidade da Pharma 4.0, a indústria brasileira precisa superar grandes desafios, tais como investimento em tecnologia digital, equipamentos e mão-de-obra qualificada. Este trabalho tem por objetivo, discutir e avaliar as perspectivas da implementação da Pharma 4.0 no Brasil, de modo a identificar quais os caminhos que a indústria brasileira precisará trilhar para iniciar e consolidar este novo modelo operacional.
The great industrial revolutions were necessary and disruptive events that had a major impact on society, bringing about economic and social development. Industry 4.0 is a concept situated within the fourth industrial revolution that brought technologies such as the internet of things, big data, artificial intelligence and cloud computing, which together are capable to connect machines and systems, creating intelligent and autonomous networks. With the implementation of new technologies, it is possible to significantly increase the agility, efficiency, flexibility, and quality of industrial production and provide new business models. In the pharmaceutical industry, this approach is called Pharma 4.0. Currently, the Brazilian pharmaceutical industry is structured along the lines of the third industrial revolution, but it has not yet reached its full magnitude, because most of the processes are manual or partially automated. With increasing demands for the manufacturing of medicines, the industries need to become more and more competitive on a global level, requiring greater investments, so that their processes are increasingly optimized and leaner, and the products are safer and more effective. To reach Pharma 4.0 maturity level, the Brazilian industry needs to overcome major challenges, such as investment in digital technology, equipment and skilled labor. This work aims to discuss and evaluate the perspectives of Pharma 4.0 implementation in Brazil, in order to identify which paths the Brazilian industry will need to follow to start and consolidate this new operational model.
The great industrial revolutions were necessary and disruptive events that had a major impact on society, bringing about economic and social development. Industry 4.0 is a concept situated within the fourth industrial revolution that brought technologies such as the internet of things, big data, artificial intelligence and cloud computing, which together are capable to connect machines and systems, creating intelligent and autonomous networks. With the implementation of new technologies, it is possible to significantly increase the agility, efficiency, flexibility, and quality of industrial production and provide new business models. In the pharmaceutical industry, this approach is called Pharma 4.0. Currently, the Brazilian pharmaceutical industry is structured along the lines of the third industrial revolution, but it has not yet reached its full magnitude, because most of the processes are manual or partially automated. With increasing demands for the manufacturing of medicines, the industries need to become more and more competitive on a global level, requiring greater investments, so that their processes are increasingly optimized and leaner, and the products are safer and more effective. To reach Pharma 4.0 maturity level, the Brazilian industry needs to overcome major challenges, such as investment in digital technology, equipment and skilled labor. This work aims to discuss and evaluate the perspectives of Pharma 4.0 implementation in Brazil, in order to identify which paths the Brazilian industry will need to follow to start and consolidate this new operational model.